Ondansetron Solution
NDC Package 60687-252-86
Package Information
Ondansetron solution is a medication used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. This formulation utilizes a solution delivery system. Marketed by American Health Packaging, this product is identified by NDC 60687-252 and is authorized under FDA application ANDA091483.
Identification & Billing
- RxCUI: 312085 - ondansetron HCl 4 MG in 5 mL Oral Solution
- RxCUI: 312085 - ondansetron 0.8 MG/ML Oral Solution
- RxCUI: 312085 - ondansetron (as ondansetron HCl dihydrate) 4 MG per 5 ML Oral Solution
- RxCUI: 312085 - ondansetron 4 MG per 5 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 60687 - American Health Packaging
- 60687-252 - Ondansetron
- 60687-252-86 - 3 TRAY in 1 CASE / 10 CUP, UNIT-DOSE in 1 TRAY (60687-252-46) / 5 mL in 1 CUP, UNIT-DOSE (60687-252-40)
- 60687-252 - Ondansetron
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 60687-252-86 identifies a specific commercial package of 3 tray in 1 case / 10 cup, unit-dose in 1 tray (60687-252-46) / 5 ml in 1 cup, unit-dose (60687-252-40) of Ondansetron, a human prescription drug labeled by American Health Packaging. This solution is formulated for oral use and contains ondansetron hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by American Health Packaging on February 05, 2019.
What are the primary indications for this medication?
This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting.
How is this American Health Packaging product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 60687025286. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.